Tag: research

  • Reflections from Japan

    Uncategorized | Melanie Welham

    At the time of writing I am heading back from the Science and Technology in Society (STS) forum meeting, held in Kyoto, Japan. The STS forum was established 13 years ago and attracts leaders from academia, industry, funding agencies and governments from around the world. The forum is very much focused on discussion and I was delighted to present as part of the plenary session on ‘Delivering healthcare to the world’. The focus of my talk was the potential of microbiome research and I was pleased at the level of interest and positive feedback I received – a Canadian delegate commented with surprise on the 2kg of microorganisms in his gut! […]

  • Dolly’s legacy – 20 years of impact

    Uncategorized | Melanie Welham

    I recently attended the ‘Coming of Age: the legacy of Dolly at 20’ symposium at The Roslin Institute, which reflected on and celebrated the impacts that have stemmed from Dolly’s creation. As I’m sure most of you are aware, BBSRC investment in the scientific programme that led to the creation of Dolly was key. However, at a more personal level, Dolly has inspired many breakthroughs in stem cell biology, my own area of science, and so attending this meeting was a real pleasure at a number of levels. […]

  • Basic research investment produces impact

    Uncategorized | Jackie Hunter

    It is always pleasing to see our investments in the research base bearing fruit whether it be in excellent publications or social and economic impact. So the announcement by GlaxoSmithKline (GSK), the Wellcome Trust Sanger Institute and the European Bioinformatics Institute of the creation of a new Centre for Therapeutic Target Validation (CTTV) at Hinxton was very welcome. The new CTTV will aim to address a wide range of human diseases and will share its data openly in the interests of accelerating drug discovery. This new centre will employ up to 50 people from the partner organisations but longer term will involve other organisations and companies who are interested in this area. It was particularly good to receive confirmation from Patrick Vallance, President of R&D at GSK, that their decision to base the CTTV in the UK was influenced by their recognition of the UK’s world class capabilities and skills in the areas of genomic, data mining and translational research. Much of this capability has been built using BBSRC funding for basic research in bioinformatics and genomics, along with other funders such as the Wellcome Trust and MRC. The CTTV will itself be based in the EBI South Building, home of the ELIXIR Hub and built with Research Council funding led by BBSRC. […]